Joshua A. Hill, MD, FIDSA
Associate Professor
Vaccine and Infectious Disease Division, Fred Hutch
Associate Professor
Clinical Research Division, Fred Hutch
Member
Immunotherapy Integrated Research Center (IIRC), Fred Hutch
Member
Translational Data Science Integrated Research Center (TDS IRC), Fred Hutch
Dr. Joshua A. Hill is a physician-researcher who sees immunocompromised patients on the infectious diseases consult service at Fred Hutch Cancer Center and UW Medical Center. His translational research program focuses on improving prevention and treatment strategies for infections in patients who are immunocompromised and has been continuously funded by the National Institutes of Health, foundations and industry partners to conduct observational studies and interventional trials.
Dr. Hill has published over 130 peer-reviewed papers in leading medical journals and is an international expert in viral infections, vaccines and infectious complications of immunotherapies, such as CAR T-cell therapy. His work has been recognized with several awards, including the International Immunocompromised Society award for excellence in research to improve patient outcomes. Dr. Hill serves on numerous local, national and international committees and expert guideline panels, and he is frequently invited as a keynote lecturer or educator at events around the world.
Other Appointments & Affiliations
Physician, Fred HutchPhysician
Fred Hutch
Associate Professor, Division of Allergy and Infectious Diseases
Department of Medicine, University of Washington
Education
Fellow, Division of Allergy and Infectious Diseases, University of Washington Medical Center, Seattle, 2012-2015
Fellow, Harvard School of Public Health, Boston, 2013
Resident, Internal Medicine Residency, Brigham and Women’s Hospital, Harvard, Boston, 2009-2012
MD, University of Texas Southwestern Medical Center, Dallas, 2009
BA, Liberal Arts Plan II Honors Program and Natural Sciences, Dean’s Scholars Program, University of Texas at Austin, 2005
Research Interests
Clinical trials of new therapies to prevent or treat infections in immunocompromised patients
Viral infections, such as human herpesvirus 6 (HHV-6), and infections in patients receiving immunotherapies such as CAR-T cells
Awards and Honors
George Santos Award for best clinical science article by a new investigator, American Society for Blood and Marrow Transplantation, 2012
Robert A. Good New Investigator Award, American Society for Blood and Marrow Transplantation, 2014
Joel Meyers Infectious Diseases Scholar, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 2014
NIH Clinical Loan Repayment Program Award, 2015
NIH/NIAID K23 Career Development Award, 2015
Caroline B. Hall Young Investigator Award, 9th International HHV-6 & 7 Conference, 2015
Amy Strelzer Manasevit Research Program Scholar Award, NMDP/ASBMT, 2018
Fialkow Scholar Award, Department of Medicine, University of Washington, 2021
Fellow, Infectious Diseases Society of America, 2021